Philip Morris’ first quarter results were shaped by robust international demand for its smoke-free products and resilient pricing power across both smoke-free and traditional cigarettes. Management attributed the strong revenue growth to double-digit volume gains in IQOS and VEEV, as well as broad-based pricing increases. CEO Jacek Olczak noted that, “Our results continue to be underpinned by three powerful drivers: strong pricing, favorable mix from the ongoing shift to smoke-free products, and volume growth led by IQOS, ZYN, and VEEV.” Despite these gains, the U.S. segment faced challenges from inventory normalization and increased promotional activity, which weighed on profitability.

Is now the time to buy PM? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Philip Morris’s Q1 Earnings Call

• Eric Serotta (Morgan Stanley) questioned the balance between prioritizing margin versus volume in international smoke-free products. CEO Jacek Olczak explained that maximizing volume is the key objective, as higher smoke-free margins already surpass those of combustibles.
• Bonnie Herzog (Goldman Sachs) asked about the confidence behind the expected U.S. improvement and willingness to sacrifice short-term profit for volume. Olczak responded that normalization of inventory and promotions, plus innovation launches, should drive better dynamics in the second half.
• Pallav Mittal (Barclays) inquired about the impact of potential excise tax increases on U.S. nicotine pouches and the growth outlook for ZYN Ultra. Olczak stated that differentiated taxation is warranted and expects ZYN Ultra to renew momentum once regulatory approval is secured.
• Andrei Andon-Ionita (Jefferies) asked about early trends in Japan post-excise tax hike and declining volumes in Germany. Olczak noted it's too soon to assess Japan but remains confident in long-term IQOS growth, and cited both market and industry weakness in Germany.
• Gerald Pascarelli (Needham) pressed about consumer migration to higher nicotine strengths in ZYN and its effect on category growth. Management acknowledged that new flavors and strengths, especially fruit-forward and higher-nicotine options, are driving the most dynamic consumer segments.

Catalysts in Upcoming Quarters

In the coming quarters, the StockStory team will be watching (1) the pace of adoption for new ZYN innovations in the U.S. and their impact on shipment volumes, (2) continued momentum and market expansion of IQOS and VEEV in key international geographies, and (3) the company’s ability to sustain pricing power and margin stability amid regulatory changes and potential excise tax shifts. Execution on cost efficiency and innovation rollouts will also be critical signposts.

Philip Morris currently trades at $165.21, up from $153.25 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).

The Best Stocks for High-Quality Investors

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.